José I Fernández‐Montequín

Therapeutic efficacy of ozone in patients with diabetic foot

Gregorio Martı́nez-Sánchez, Saied Mohammed Al‐Dalain, Silvia Menéndez et al. · European Journal of Pharmacology · 2005 · 304 citations

Health Professions, Podiatric Medicine, Surgery +14

Intra‐lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo‐controlled, double‐blind study

José I Fernández‐Montequín, Carmen Valenzuela‐Silva, Odalys González Díaz et al. · International Wound Journal · 2009 · 134 citations · Full text

Health Professions, Podiatric Medicine, Surgery +17

Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure

José I Fernández‐Montequín, Blas Y Betancourt, Gisselle Leyva‐Gonzalez et al. · International Wound Journal · 2009 · 104 citations · Full text

Health Professions, Pharmacotherapy, Surgery +16

Intralesional injections of Citoprot‐P^® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation

José I Fernández‐Montequín, Ena Infante‐Cristiá, Carmen Valenzuela‐Silva et al. · International Wound Journal · 2007 · 78 citations · Full text

Health Professions, Pharmacotherapy, Surgery +17

Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds

Jorge Berlanga Acosta, William Savigne, Calixto Valdez et al. · International Wound Journal · 2006 · 77 citations · Full text

Health Professions, Surgery, Diabetology +16